Esomeprazole Increases Airway Surface Liquid pH in Primary Cystic Fibrosis Epithelial Cells
Respiratory failure, driven by airways mucus obstruction, chronic inflammation and bacterial infections, is the main cause of mortality and morbidity in people with cystic fibrosis (CF) due to defects in the Cl- and HCO3− transport activity of the CF Transmembrane conductance Regulator (CFTR). Most...
Main Authors: | Livia Delpiano, Joseph J. Thomas, Annabel R. Yates, Sarah J. Rice, Michael A. Gray, Vinciane Saint-Criq |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01462/full |
Similar Items
-
EVALUATION OF PSORIASIS TREATMENT WITH ESOMEPRAZOLE - A PILOT STUDY
by: Mauro BAFUTTO, et al. -
Pharmacokinetics of esomeprazole following intravenous and oral administration in healthy dogs
by: Cook EK, et al.
Published: (2016-08-01) -
Esomeprazole: a Safe Alternative to Lansoprazole Allergy?
by: Muammer Kara, et al.
Published: (2014-08-01) -
Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway
by: Afshin Ebrahimpour, et al.
Published: (2021-05-01) -
Clinical and pharmacoeconomic profile of esomeprazole in acid-related diseases
by: Orietta Zaniolo
Published: (2006-09-01)